Mode
Text Size
Log in / Sign up
N/A N=100 Treatment

Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System.

Ventricular Fibrillation · Ventricular Tachycardia

Enrolled (actual)
100
Serious AEs
6.0%
Results posted
Feb 2021
Primary outcome: Primary: Number of Patients With Skin Symptoms — 0 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Internal defibrillation during cardiac surgery, using the iD-system (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
SMART Clinical Products BV
Primary completion
May 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Patients With Skin Symptoms
PRIMARY
Number of Patients With Increased Troponin-t Level Classified as Adverse Event
5
PRIMARY
Number of Patients Where the iD-System TM Fails
1
PRIMARY
Ease of Use of the iD-System as Assessed Via Investigator Questionnaire
0; 0; 91; 0; 0; 0

Summary

The main aim is to evaluate the safety and efficacy of the iD-System™, One-handed Disposable Internal Defibrillation System The device is made for manual defibrillation during intra-thoracic procedure, by transferring a shock from a defibrillation device to the patient's heart, in combination with the iD-Electrode. The device will be used when the patient reaches a stage of ventricular fibrillation or rapid ventricular tachycardia during cardiac surgery.

Eligibility Criteria

Inclusion Criteria

  • All races and ethnicity (>18 years)
  • Written informed consent form (ICF) has to be obtained from the patient.
  • Elective surgery: cardiac surgery on pump (CPB)
  • Coronary artery bypass surgery
  • Heart valve repair and/or replacement
  • Mini sternotomy
  • Median sternotomy
  • Redo surgery

Exclusion Criteria

  • Patients without cardiopulmonary bypass (referred to as heart-lung machine or pump)
  • Emergency surgery without a sufficient amount of time to explain and ask for ICF
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04011631). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search